AAAAAA

   
Results: 1-12 |
Results: 12
Fluoroquinolone pharmacodynamics
Authors: Drusano, GL Preston, SL Owens, RC Ambrose, PG
Citation: Gl. Drusano et al., Fluoroquinolone pharmacodynamics, CLIN INF D, 33(12), 2001, pp. 2091-2092
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens
Authors: Owens, RC Tessier, P Nightingale, CH Ambrose, PG Quintiliani, R Nicolau, DP
Citation: Rc. Owens et al., Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens, INT J ANT A, 17(6), 2001, pp. 483-489
Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
Authors: Owens, RC
Citation: Rc. Owens, Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes, PHARMACOTHE, 21(3), 2001, pp. 301-319
Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections
Authors: Owens, RC
Citation: Rc. Owens, Choosing the ideal antibiotic therapy and the role of the newer fluoroquinolones in respiratory tract infections, AM J M CARE, 6(8), 2000, pp. S442-S447
New antibiotics in pulmonary and critical care medicine: Focus on advancedgeneration quinolones and cephalosporins
Authors: Ambrose, PG Owens, RC
Citation: Pg. Ambrose et Rc. Owens, New antibiotics in pulmonary and critical care medicine: Focus on advancedgeneration quinolones and cephalosporins, SEM RESP CR, 21(1), 2000, pp. 19-32
Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS
Authors: McNabb, J Owens, RC Xuan, DW Quintiliani, R Nightingale, CH Nicolau, DP
Citation: J. Mcnabb et al., Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS, INT J ANT A, 16(1), 2000, pp. 37-43
Antimicrobial pharmacodynamics
Authors: Ambrose, PG Owens, RC Grasela, D
Citation: Pg. Ambrose et al., Antimicrobial pharmacodynamics, MED CLIN NA, 84(6), 2000, pp. 1431
Clinical use of the fluoroquinolones
Authors: Owens, RC Ambrose, PG
Citation: Rc. Owens et Pg. Ambrose, Clinical use of the fluoroquinolones, MED CLIN NA, 84(6), 2000, pp. 1447
Clinical role of fluoroquinolones in patients with respiratory tract infections
Authors: Quintiliani, R Owens, RC Grant, EM
Citation: R. Quintiliani et al., Clinical role of fluoroquinolones in patients with respiratory tract infections, INF DIS C P, 8, 1999, pp. S28-S41
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia
Authors: Onyeji, CO Bui, KQ Owens, RC Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Co. Onyeji et al., Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia, INT J ANT A, 12(2), 1999, pp. 107-114
Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study
Authors: Keung, ACF Owens, RC Eller, MG Weir, SJ Nicolau, DP Nightingale, CH
Citation: Acf. Keung et al., Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study, ANTIM AG CH, 43(5), 1999, pp. 1230-1233
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae
Authors: Lacy, MK Owens, RC Xu, XW Nicolau, DP Quintiliani, R Nightingale, CH
Citation: Mk. Lacy et al., Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae, INT J ANT A, 10(4), 1998, pp. 279-283
Risultati: 1-12 |